Approval · Notice of Compliance 14646 · 2013
VARILRIX: Notice of Compliance 14646
Issued August 14, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14646
- Date
- August 14, 2013
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARILRIX | Not yet assigned | — |
Medicinal ingredients
- VARICELLA ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA/MERCK STRAIN) 1,995 UNIT per 0.5ML